Lexology January 15, 2026
Amid increasing investor interest in the telehealth sector, a recent Department of Justice (“DOJ”) prosecution involving Done Global underscores evolving enforcement risks for telehealth platforms, management services organizations (“MSOs”), and the investors that support them. In late 2025, a federal jury in the Northern District of California convicted the founder and chief executive officer and the clinical president of Done Global, a virtual behavioral health company, in what DOJ has described as its first criminal drug distribution prosecution arising out of telemedicine prescribing practices.1 DOJ subsequently reinforced the verdict by obtaining a superseding indictment of the company on substantively similar allegations.2
Background
Done Global operated a subscription-based telehealth platform focused on diagnosing and treating attention-deficit/hyperactivity disorder. The company launched around...
Today's Sponsors
Today's Sponsor